Innate immunity for biodefense: a strategy whose time has come (Q36335919)

13 August 2017

1 reference

title

Innate immunity for biodefense: a strategy whose time has come (English)

1 reference

13 August 2017

4

Gary B Huffnagle

1 reference

13 August 2017

Catherine Amlie-Lefond

1

1 reference

13 August 2017

David A Paz

2

1 reference

13 August 2017

Mary P Connelly

3

1 reference

13 August 2017

Noel T Whelan

5

1 reference

13 August 2017

Harry T Whelan

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

24 October 2005

1 reference

The Journal of Allergy and Clinical Immunology

13 August 2017

1 reference

13 August 2017

116

1 reference

13 August 2017

6

1 reference

13 August 2017

1334-1342

1 reference

CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice

13 August 2017

1 reference

12 December 2020

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

12 December 2020

Thymosin alpha1. SciClone Pharmaceuticals

1 reference

12 December 2020

Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling

1 reference

12 December 2020

Peginterferon alfa-2a: a review of approved and investigational uses

1 reference

12 December 2020

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

1 reference

12 December 2020

The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis

1 reference

12 December 2020

Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

1 reference

12 December 2020

Using imiquimod for genital warts in female patients

1 reference

12 December 2020

Activation of airway epithelial cells by toll-like receptor agonists

1 reference

12 December 2020

Biological Activity of Peptide SCV-07 Against Murine Tuberculosis

1 reference

12 December 2020

Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections

1 reference

12 December 2020

Heterogeneity in the human response to immunostimulatory CpG oligodeoxynucleotides

1 reference

12 December 2020

Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists

1 reference

12 December 2020

Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling

1 reference

12 December 2020

Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice

1 reference

12 December 2020

Antiviral chemotherapy and prophylaxis of viral respiratory disease

1 reference

12 December 2020

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

12 December 2020

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

1 reference

12 December 2020

Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products

1 reference

12 December 2020

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

1 reference

12 December 2020

CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection

1 reference

12 December 2020

A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner

1 reference

12 December 2020

CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells

1 reference

12 December 2020

Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.

1 reference

12 December 2020

Structure-activity relationship of synthetic toll-like receptor 4 agonists

1 reference

12 December 2020

Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.

1 reference

12 December 2020

Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity

1 reference

12 December 2020

Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs

1 reference

12 December 2020

Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator

1 reference

12 December 2020

Innate immune activation as a broad-spectrum biodefense strategy Prospects and research challenges

1 reference

12 December 2020

10.1016/J.JACI.2005.08.048

Identifiers

DOI

1 reference

13 August 2017

1 reference